Publication

Challenges and successes in the treatment of hemophilia: the story of a patient with severe hemophilia A and high-titer inhibitors.

Downloadable Content

Persistent URL
Last modified
  • 05/14/2025
Type of Material
Authors
    Hussain I. Saba, University of South FloridaDuc Tran Jr, Emory University
Language
  • English
Date
  • 2012
Publisher
  • Dove Press
Publication Version
Copyright Statement
  • © 2012 Saba and Tran, Jr, publisher and licensee Dove Medical Press Ltd.
Final Published Version (URL)
Title of Journal or Parent Work
Volume
  • 3
Start Page
  • 17
End Page
  • 23
Abstract
  • In the past, patients with severe hemophilia have suffered a substantially reduced quality of life with frequent bleeding episodes, disabling arthropathy, and shorter life expectancy. In addition, methods of treatment and management have been costly and time-consuming, and have placed a considerable burden on patients' physical and psychological well-being. With the advent of the on-demand therapy and prophylactic treatment paradigm, patients have been able to receive care with less interruption of daily activities. Treatments may be more challenging for hemophiliacs with inhibitors to replacement factor; however, recent advances in the use of bypassing agents and immune tolerance therapy have enabled them to aggressively manage their disease while maintaining their independence. This review focuses on the challenges of treating such a severe hemophiliac through examination of the lifetime experience of a young adult male with a severe form of congenital hemophilia A. At this stage of his life, the patient has minimal disabilities and is inhibitor-free through optimal care and strong family support. His aspiration to pursue a productive life has led him to a career in medicine. After receiving his medical degree, he pursued a specialty in the treatment of hemophilia. By assisting other hemophilia patients, he exemplifies both the rewards of persevering through episodes of bleeding and other complications and the fact that disabilities can be minimized when managed meticulously and in a timely fashion to enable a productive and dignified life.
Author Notes
  • Hussain I Saba, Director of Hemophilia, Hemostasis, and Thrombosis Center, University of South Florida Medical Center, Department of Medicine, 12901 Bruce B. Downs Blvd, MDC 19, Tampa, FL 33612, USA, Tel +1 813 974 7074, Fax +1 813 974 9476, Email hsaba@health.usf.edu
Keywords
Research Categories
  • Health Sciences, Health Care Management
  • Health Sciences, Public Health

Tools

Relations

In Collection:

Items